27.25
0.20 (0.74%)
0.20 (0.74%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 352,177 |
|
|||||
| News | - | ||||||
| Day High | 27.405 | Low High |
|||||
| Day Low | 26.34 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| iTeos Therapeutics Inc | ITOS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.20 | 0.74% | 27.25 | 16:18:28 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 26.71 | 26.34 | 27.405 | 27.25 | 27.05 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,922 | 352,177 | $ 27.01 | $ 9,514,001 | - | 16.21 - 52.43 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:11:23 | 2 | $ 25.89 | USD |
Period:
Draw Mode:
iTeos Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 968.48M | 35.54M | 23.36M | $ 344.78M | $ 224.69M | 5.61 | 3.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -1.04M | 0.30% |
iTeos Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ITOS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 25.30 | 27.405 | 23.80 | 25.44 | 279,497 | 1.95 | 7.71% |
| 1 Month | 22.01 | 28.05 | 21.55 | 25.11 | 366,751 | 5.24 | 23.81% |
| 3 Months | 19.25 | 28.05 | 16.21 | 20.80 | 438,785 | 8.00 | 41.56% |
| 6 Months | 36.31 | 37.88 | 16.21 | 26.31 | 434,847 | -9.06 | -24.95% |
| 1 Year | 24.92 | 52.43 | 16.21 | 30.91 | 383,575 | 2.33 | 9.35% |
| 3 Years | 19.70 | 52.43 | 16.21 | 29.56 | 329,401 | 7.55 | 38.32% |
| 5 Years | 19.70 | 52.43 | 16.21 | 29.56 | 329,401 | 7.55 | 38.32% |
iTeos Therapeutics Description
| ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody. |